Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

October 30, 2018 Leave a comment 1,921 Views

AMPEL BioSolutions announced proof-of-principle for a multi-pronged approach to rank small molecules and biologics for safe, effective treatment of patients with Systemic Lupus Erythematosus (SLE) and...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Stelara

Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

DirectRMDB – a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology

Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq

MATQ_Drop – Multiple-Annealing-and-Tailing-based Quantitative scRNA-seq in Droplets

Featured RNA-Seq Job – Research Technician II – Single Cell RNA Sequencing

IMMUcan scDB – a fully integrated scRNA-seq database exclusively dedicated to human cancer

Correspondence analysis for dimension reduction, batch integration, and visualization of single-cell RNA-seq data

Mutant KRAS signaling drives alternative splicing in lung cancer cells